122 related articles for article (PubMed ID: 32931402)
1. Reply to K. Beiske et al.
Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
J Clin Oncol; 2020 Nov; 38(31):3720-3721. PubMed ID: 32931402
[No Abstract] [Full Text] [Related]
2. Computer-aided prognosis of neuroblastoma: detection of mitosis and karyorrhexis cells in digitized histological images.
Sertel O; Catalyurek UV; Shimada H; Gurcan MN
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():1433-6. PubMed ID: 19963746
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
4. Reply to N.-K.V. Cheung et al.
Matthay KK; London WB; Maris J; Adamson PC; Park JR
J Clin Oncol; 2014 Dec; 32(36):4174-5. PubMed ID: 25403223
[No Abstract] [Full Text] [Related]
5. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group.
Joshi VV; Chatten J; Sather HN; Shimada H
Mod Pathol; 1991 Mar; 4(2):139-47. PubMed ID: 2047378
[TBL] [Abstract][Full Text] [Related]
7. Reply to Mohlin et al.: High levels of
Westerlund I; Shi Y; Toskas K; Fell SM; Li S; Södersten E; Schlisio S; Holmberg J
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10859-E10860. PubMed ID: 29233947
[No Abstract] [Full Text] [Related]
8. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
9. Reply to J. Stenman et al.
La Quaglia MP; Haas-Kogan D; Park J; Kreissman SG; von Allmen D; Davidoff A; London WB; Khanna G
J Clin Oncol; 2017 Jun; 35(17):1966-1967. PubMed ID: 28422554
[No Abstract] [Full Text] [Related]
10. Comparative study of the degree of differentiation of neuroblastoma and mean numbers of nucleolar organiser regions.
Egan M; Raafat F; Crocker J; Williams D
J Clin Pathol; 1988 May; 41(5):527-31. PubMed ID: 3384982
[TBL] [Abstract][Full Text] [Related]
11. Modulation of functional and optimal (Na+-K+)ATPase activity during the cell cycle of neuroblastoma cells.
Mummery CL; Boonstra J; Van Der Saag PT; de Laat SW
J Cell Physiol; 1981 Apr; 107(1):1-9. PubMed ID: 6260824
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Campbell K; Shyr D; Bagatell R; Fischer M; Nakagawara A; Nieto AC; Brodeur GM; Matthay KK; London WB; DuBois SG
Pediatr Blood Cancer; 2019 Aug; 66(8):e27819. PubMed ID: 31115156
[TBL] [Abstract][Full Text] [Related]
13. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
14. Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
Qi K; Li Y; Huang K; Xiong X; Chuchu F; Zhang C; Weng W
Biomed Pharmacother; 2019 May; 113():108665. PubMed ID: 30889490
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
[TBL] [Abstract][Full Text] [Related]
16. Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors.
Beiske K; Ikegaki N; Shimada H
J Clin Oncol; 2020 Nov; 38(31):3719-3720. PubMed ID: 32931395
[No Abstract] [Full Text] [Related]
17. Cation transport and growth regulation in neuroblastoma cells. Modulations of K+ transport and electrical membrane properties during the cell cycle.
Boonstra J; Mummery CL; Tertoolen LG; Van Der Saag PT; De Laat SW
J Cell Physiol; 1981 Apr; 107(1):75-83. PubMed ID: 7217225
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index.
Gestblom C; Hoehner JC; Påhlman S
Eur J Cancer; 1995; 31A(4):458-63. PubMed ID: 7576945
[TBL] [Abstract][Full Text] [Related]
19. RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with
Ronckers CM; Tytgat L; van den Heuvel-Eibrink MM; Teepen J; Kremer LCM; Clement S; van Santen HM
Eur J Cancer; 2017 May; 77():21-23. PubMed ID: 28359832
[No Abstract] [Full Text] [Related]
20. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.
Pope WB; Lambert MP; Leypold B; Seupaul R; Sletten L; Krafft G; Klein WL
Exp Neurol; 1994 Apr; 126(2):185-94. PubMed ID: 7925819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
